Global Industry Analysts, Inc., June 2010, Pages: 402
CysticFibrosis - Global Strategic Business Report This report analyzes the US market for CysticFibrosis in Millions of US$. Annual estimates and forecasts are provided for the period of 2007
Informa Healthcare, March 2010, Pages: 1044
CysticFibrosis The median age of survival for those with cysticfibrosis has risen considerably in recent years. This text thoroughly examines the developments and breakthroughs which have led
Fore Pharma, Aug 2011, Pages: 13
Global CysticFibrosis Drug Pipeline Capsule - 2011 Fore Pharma’s latest report ‘Global CysticFibrosis Drug Pipeline Capsule – 2011’ is an outline of all the key research and development (R
Decision Resources, Inc., June 2008, Pages: 39
CysticFibrosis: Will New Agents Emerge as First-Line Therapies? The cysticfibrosis (CF) market is poised for significant change. The next generation of CF treatments all target the central
Decision Resources, Inc., April 2011, Pages: 38
Will the Approval of New Agents Redefine the CysticFibrosis Market? The cysticfibrosis (CF) pipeline includes agents that target not only the symptoms of the disease but also the main cause
Fore Pharma, Jan 2012, Pages: 13
Global CysticFibrosis Drug Pipeline Capsule - 2012 Fore Pharma’s latest report ‘Global CysticFibrosis Drug Pipeline Capsule – 2012’ is an outline of all the key research and development (R
Datamonitor, Oct 2011, Pages: 68
R&D Trends: CysticFibrosis - New drugs tackle both cause and effect Two decades after the identification of the cysticfibrosis transmembrane conductance regulator protein, approved drugs capable
Life Science Analytics, March 2011, Pages: 201
CysticFibrosis Therapy Area Pipeline Report CysticFibrosis Therapy Area Pipeline Report contains detailed information on the cysticfibrosis drug pipeline. This report provides insight
Life Science Analytics, March 2008, Pages: 62
Respiratory and Pulmonary System CysticFibrosis "Respiratory and Pulmonary System CysticFibrosis " contains detailed information on the current drug pipeline. This report provides insight
GlobalData, March 2011, Pages: 4
Vertex's VX770 Is Poised To Become The First Targeted Therapy To Be Approved In CysticFibrosis Vertex’s VX770 Is Poised To Become The First Targeted Therapy To Be Approved In CysticFibrosis
ICON Group International, Jan 2011, Pages: 194
The 2011-2016 World Outlook for CysticFibrosis Drugs WHAT IS LATENT DEMAND AND THE P.I.E.?
The concept of latent demand is rather subtle. The term latent typically refers to something
ICON Group International, Jan 2011, Pages: 329
The 2011 Report on CysticFibrosis Drugs: World Market Segmentation by City Market Potential Estimation Methodology
Overview
This study covers the world outlook for CysticFibrosis drugs across more
Life Science Analytics, June 2007, Pages: 11
Respiratory and Pulmonary System - CysticFibrosis Drug Pipeline Report Life Science Analytics, "Respiratory and Pulmonary System - CysticFibrosis Drug Pipeline Report" contains detailed information